This month, a new strain of HIV was discovered for the first time in nearly two decades, providing the global community with a more complete map of how the virus evolves.
Monitoring diagnosis, retention in care and viral load suppression in children testing HIV polymerase chain reaction-positive in two districts in South Africa
Impact of male partner involvement on mother-to-child transmission of HIV and HIV-free survival among HIV-exposed infants in rural South Africa: Results from a two phase randomised controlled trial
12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study
The Southern African HIV Clinicians Society’s biannual conference, held in Johannesburg, South Africa, from 24-27 October 2018, focused on clinical content for HIV and TB health care workers in the region and featured a wide range of topics, from new antiretroviral drugs, AIDS-related complications, and opportunistic infections, to promoting adherence and ethical issues.
JAIDS supplement: Post-program learning and knowledge from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative
Baylor-Malawi, with USAID funding, has developed a special JAIDS supplement featuring 11 articles which highlight lessons and best practices from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.
Enhancing HIV Retention and Clinical Outcomes in Tanzania through Pediatric- and Adolescent-Friendly Services
Despite global reductions in AIDS-related deaths among adults, the rate for children increased by 50 percent. This increase points to inadequate testing, counselling, and treatment coverage and poor retention in services for these children. Pediatric- and adolescent-friendly health services have the potential to improve retention and clinical outcomes among children living with HIV. This study was conducted to provide evidence of the effectiveness of pediatric- and adolescent-friendly clinics in Kigoma, Tanzania.
Lopinavir/ritonavir (LPV/r) pellets are a new formulation of a pediatric HIV medicine. The LPV/r Pellet Toolkit provides information on how to implement rollout of LPV/r pellets into the national health care system in the Rollout Planning and Management section. The toolkit also provides clinical information on LPV/r pellets in the Health Care Worker section, including recommendations on dosing and administration of the medication, as well as resources for working with caregivers.
About the course